Trial intelligence / Profile preview

Oxymorphone Oral Liquid in Pediatric Postoperative Pain

NCT01210352Phase 3Completed

Sponsor
Endo International plc
Start
Dec 2010
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of oxymorphone in postoperative pain, sponsored by Endo International plc. Started Dec 2010; status: completed.

02

Drugs

oxymorphone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01210352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01210352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call